Use access key #2 to skip to page content.
$50.91 -0.03 (-0.06%)
5/16/2008 4:00 PM

LifeCell Corp (LIFC)

CAPS Rating:
****

The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

View All Commentary (LIFC)

Recs

0

Avatar RetireFree (90.30) Submitted: 5/01/08 4:13 PM : Outperform Start Price: $50.84 LIFC Score: -0.87

THe company is slowly getting established in the world of providing material to treat burns and graft issues. There efforts will continue to be seen positive by investors

Report this Post Replies: 0 | Reply

Featured Broker Partners